Abstract

The ability to diagnose the early onset of disease, rapidly, non-invasively and unequivocally has multiple benefits. These include the early intervention of therapeutic strategies leading to a reduction in morbidity and mortality, and the releasing of economic resources within overburdened health care systems. Some of the routine clinical tests currently in use are known to be unsuitable or unreliable. In addition, these often rely on single disease markers which are inappropriate when multiple factors are involved. Many diseases are a result of metabolic disorders, therefore it is logical to measure metabolism directly. One of the strategies employed by the emergent science of metabolomics is metabolic fingerprinting; which involves rapid, high-throughput global analysis to discriminate between samples of different biological status or origin. This review focuses on a selective number of recent studies where metabolic fingerprinting has been forwarded as a potential tool for disease diagnosis using infrared and Raman spectroscopies.

Keywords

MetabolomicsDiseaseMetabolic diseaseMedicineIntensive care medicineComputational biologyComputer scienceBioinformaticsBiologyPathologyInternal medicine

Affiliated Institutions

Related Publications

Overdiagnosis in Cancer

This article summarizes the phenomenon of cancer overdiagnosis-the diagnosis of a "cancer" that would otherwise not go on to cause symptoms or death. We describe the two prerequ...

2010 JNCI Journal of the National Cancer I... 1543 citations

Publication Info

Year
2006
Type
review
Volume
131
Issue
8
Pages
875-875
Citations
598
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

598
OpenAlex

Cite This

David I. Ellis, Royston Goodacre (2006). Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. The Analyst , 131 (8) , 875-875. https://doi.org/10.1039/b602376m

Identifiers

DOI
10.1039/b602376m